Vaccinex, Inc. (NASDAQ:VCNX – Get Free Report) traded down 11.3% on Monday . The company traded as low as $0.65 and last traded at $0.92. 1,541 shares traded hands during trading, a decline of 97% from the average session volume of 57,732 shares. The stock had previously closed at $1.04.
Vaccinex Stock Down 11.3%
The stock has a market cap of $2.40 million, a P/E ratio of -0.02 and a beta of 1.10. The firm has a 50 day simple moving average of $0.77 and a 200-day simple moving average of $1.52.
Vaccinex Company Profile
Vaccinex, Inc, a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D.
Featured Stories
- Five stocks we like better than Vaccinex
- Overbought Stocks Explained: Should You Trade Them?
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
- Trading Halts Explained
- What Ray Dalio’s Latest Moves Tell Investors
- How to Plot Fibonacci Price Inflection Levels
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
Receive News & Ratings for Vaccinex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vaccinex and related companies with MarketBeat.com's FREE daily email newsletter.
